PEG — Pharma Equity A/S Cashflow Statement
0.000.00%
Last trade - 00:00- DKK193.34m
- DKK201.48m
Annual cashflow statement for Pharma Equity A/S, fiscal year end - December 31st, DKK millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -14.4 | -32.9 | 5.39 | 3.48 | -26.8 |
| Depreciation | |||||
| Non-Cash Items | 12.7 | 23.9 | -7.45 | -8.28 | 4.49 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.43 | -0.9 | -0.03 | 1.93 | 5.25 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.274 | -9.9 | -2.09 | -2.87 | -16.6 |
| Capital Expenditures | -2.05 | — | — | — | -0.073 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 3.7 | 0 | 0 | — | — |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 1.65 | 0 | 0 | — | -0.073 |
| Financing Cash Flow Items | -1.05 | 1.05 | 0 | — | 8.34 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -1.38 | 9.9 | 2.09 | 3.06 | 17.1 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0 | 0 | 0 | 0.182 | 0.363 |